EKF Diagnostics Holdings plc (AIM: EKF), the AIM listed medical diagnostics business, announces that it will release its interim results for the six months ended 30 June 2017 on Monday 11 September 2017.
Investor briefing
A briefing for all investors will take place on Monday 11 September at Côte Brasserie, 26 Ludgate Hill, London, EC4M 7DR from 4.30pm for a 4.45pm start, and will be followed by drinks and an opportunity to network. If you would like to register for the investor presentation, please contact Walbrook PR on 020 7933 8780 or email ekf@walbrookpr.com
EKF Diagnostics Holdings plc Christopher Mills, Non-Executive Chairman Julian Baines, CEO Richard Evans, FD & COO |
www.ekfdiagnostics.com Tel: 029 2071 0570 |
N+1 Singer (Nomad & Broker) Alex Price / Shaun Dobson / Ali Laughton-Scott | Tel: 020 7496 3000 |
Walbrook PR Limited |
Tel: 020 7933 8780 or ekf@walbrookpr.com Mob: 07980 541 893 / 07584 391 303 |
EKF Diagnostics Holdings plc published this content on 31 August 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 31 August 2017 08:37:01 UTC.
Original documenthttps://www.ekfdiagnostics.com/notice-of-results-investor-results-presentation.html
Public permalinkhttp://www.publicnow.com/view/D87A157A1CB9E18DAF7732655FBA3C4A1E12C2A3